ACE2 and infection: Human (h) ACE2 transgenic mice, intranasally inoculated with SARS-CoV-2, develop severe pulmonary pathology with viral replication in the lungs and intestines, at 1-day post infection (dpi) and severe pulmonary pathology 5 dpi.